Literature DB >> 34744319

Evaluation of a Refined Implantable Resonator for Deep-Tissue EPR Oximetry in the Clinic.

Eunice Y Chen1, Dan Tse2, Huagang Hou2, Wilson A Schreiber2, Philip E Schaner3, Maciej M Kmiec2, Kendra A Hebert2, Periannan Kuppusamy2, Harold M Swartz2,3, Benjamin B Williams2,3.   

Abstract

OBJECTIVES: (1) Summarize revisions made to the implantable resonator (IR) design and results of testing to characterize biocompatibility;(2) Demonstrate safety of implantation and feasibility of deep tissue oxygenation measurement using electron paramagnetic resonance (EPR) oximetry. STUDY
DESIGN: In vitro testing of the revised IR and in vivo implantation in rabbit brain and leg tissues.
METHODS: Revised IRs were fabricated with 1-4 OxyChips with a thin wire encapsulated with two biocompatible coatings. Biocompatibility and chemical characterization tests were performed. Rabbits were implanted with either an IR with 2 oxygen sensors or a biocompatible-control sample in both the brain and hind leg. The rabbits were implanted with IRs using a catheter-based, minimally invasive surgical procedure. EPR oximetry was performed for rabbits with IRs. Cohorts of rabbits were euthanized and tissues were obtained at 1 week, 3 months, and 9 months after implantation and examined for tissue reaction.
RESULTS: Biocompatibility and toxicity testing of the revised IRs demonstrated no abnormal reactions. EPR oximetry from brain and leg tissues were successfully executed. Blood work and histopathological evaluations showed no significant difference between the IR and control groups.
CONCLUSIONS: IRs were functional for up to 9 months after implantation and provided deep tissue oxygen measurements using EPR oximetry. Tissues surrounding the IRs showed no more tissue reaction than tissues surrounding the control samples. This pre-clinical study demonstrates that the IRs can be safely implanted in brain and leg tissues and that repeated, non-invasive, deep-tissue oxygen measurements can be obtained using in vivo EPR oximetry.

Entities:  

Keywords:  EPR; electron paramagnetic resonance; implantable resonator; oximetry

Year:  2021        PMID: 34744319      PMCID: PMC8570533          DOI: 10.1007/s00723-021-01376-5

Source DB:  PubMed          Journal:  Appl Magn Reson        ISSN: 0937-9347            Impact factor:   0.974


  47 in total

1.  Fast EPR imaging at 300 MHz using spinning magnetic field gradients.

Authors:  Yuanmu Deng; Guanglong He; Sergy Petryakov; Periannan Kuppusamy; Jay L Zweier
Journal:  J Magn Reson       Date:  2004-06       Impact factor: 2.229

2.  Implantable resonators--a technique for repeated measurement of oxygen at multiple deep sites with in vivo EPR.

Authors:  Hongbin Li; Huagang Hou; Artur Sucheta; Benjamin B Williams; Jean P Lariviere; Md Nadeem Khan; Piotr N Lesniewski; Bernard Gallez; Harold M Swartz
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

Authors:  M Hockel; K Schlenger; B Aral; M Mitze; U Schaffer; P Vaupel
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

4.  A Versatile High Speed 250 MHz Pulse Imager for Biomedical Applications.

Authors:  Boris Epel; Subramanian V Sundramoorthy; Colin Mailer; Howard J Halpern
Journal:  Concepts Magn Reson Part B Magn Reson Eng       Date:  2008-07-10       Impact factor: 1.176

5.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

6.  Recurrent low-dose chemotherapy to inhibit and oxygenate head and neck tumors.

Authors:  Nadeem Khan; Huagang Hou; Sassan Hodge; Muthulakshmi Kuppusamy; Eunice Y Chen; Alan Eastman; Periannan Kuppusamy; Harold M Swartz
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 7.  18F-Fluoromisonidazole in tumor hypoxia imaging.

Authors:  Zuoyu Xu; Xiao-Feng Li; Hongyan Zou; Xilin Sun; Baozhong Shen
Journal:  Oncotarget       Date:  2017-10-07

Review 8.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

Review 9.  Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways.

Authors:  Brita Singers Sørensen; Michael R Horsman
Journal:  Front Oncol       Date:  2020-04-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.